(Journal of Leukocyte Biology. 2001;69:899-906.)
© 2001
by Society for Leukocyte Biology
Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection
G. Godaly,
G. Bergsten,
L. Hang,
H. Fischer,
B. Frendéus,
A.-C. Lundstedt,
M. Samuelsson,
P. Samuelsson and
Catharina Svanborg
Department of Laboratory Medicine, Division of Microbiology, Immunology and Glycobiology (MIG), Lund University, Lund, Sweden, and The Wright Flemming Institute, Imperial College School of Medicine, London, England
Correspondence: Catharina Svanborg, Department of Laboratory Medicine, Division of MIG, Lund University, Sölvegatan 23, 223 62 Lund, Sweden. E-mail: catharina.svanborg{at}mig.lu.se
 |
ABSTRACT
|
|---|
Neutrophil migration to infected mucosal sites involves a series of
complex interactions with molecules in the lamina propria and at the
epithelial barrier. Much attention has focussed on the vascular
compartment and endothelial cells, but less is known about the
molecular determinants of neutrophil behavior in the periphery. We have
studied urinary tract infections (UTIs) to determine the events that
initiate neutrophil recruitment and interactions of the recruited
neutrophils with the mucosal barrier. Bacteria activate a chemokine
response in uroepithelial cells, and the chemokine repertoire depends
on the bacterial virulence factors and on the specific signaling
pathways that they activate. In addition, epithelial chemokine receptor
expression is enhanced. Interleukin (IL)-8 and CXCR1 direct neutrophil
migration across the epithelial barrier into the lumen. Indeed, mIL-8Rh
knockout mice showed impaired transepithelial neutrophil migration,
with tissue accumulation of neutrophils, and these mice developed renal
scarring. They had a defective antibacterial defense and developed
acute pyelonephritis with bacteremia. Low CXCR1 expression was also
detected in children with acute pyelonephritis. These results
demonstrate that chemokines and chemokine receptors are essential to
orchestrate a functional antimicrobial defense of the urinary tract
mucosa. Mutational inactivation of the IL-8R caused both acute disease
and chronic tissue damage.
Key Words: urinary tract infection • bacterial virulence factors • neutrophil migration • innate immunity • chemokines
|
INTRODUCTION
|
|---|
The behavior of neutrophils in peripheral compartments is
influenced by the stimulus that initiates the inflammatory cascade.
Depending on its molecular characteristics, this stimulus targets
specific cell types at the site of tissue attack, directs the response
pathways of these cells, and selects the profile of inflammatory
mediators. In this way, the stimulus sets the stage for subsequent
activation of the inflammatory cascade (Fig. 1
).
View larger version (39K):
[in this window]
[in a new window]
|
Figure 1. The two-step model for neutrophil recruitment and mucosal
inflammation. Signal 1: bacterial attachment to mucosal cells activates
a first inflammatory response. The adhesin receptor interaction may
trigger different signal transduction pathways, depending on the
receptor specificity and the signaling properties of the receptor
molecule. Furthermore, attachment delivers other virulence factors to
the tissues. These include toxins, invasins etc. The figure illustrates
this concept for P fimbriae that bind to glycolipid receptors and
recruit TLR4 as coreceptors. Signal 2: the released proinflammatory
mediators constitute the second inflammatory signal. Chemokines recruit
inflammatory cells, and chemokine receptors direct cellular interaction
with the mucosal barrier. Inflammation is enhanced by the different
mediators released from the recruited cells, and subsequent steps in
the inflammatory process determine the balance between health and
disease. We propose that patients with UTI can be assigned into
different groups depending on the magnitude of these two signals.
"High responders" are the patients in whom inflammation occurs most
readily. The high-responder individual has a very active signal 1 and
signal 2, constituting the basis for symptomatic disease. If the
inflammatory response is fully functional, the patient may develop
transient symptoms but rapidly clears the infection. Individuals with a
high but dysfunctional response develop severe acute infection, and
chronic tissue pathology may result. "Low responders" do not
activate signal 1, due to genetic or reactive unresponsiveness, and
remain apparently refractory to the bacteria. They resemble the
Tlr4-deficient mice, in which infection establishes without triggering
an inflammatory response, and may become asymptomatic carriers.
|
|
Infectious agents are excellent tools to study these early
events. Most infections begin at mucosal sites where microbes from the
external environment make contact with host tissues. This interaction
may lead to peaceful coexistence between microbe and host, as in the
case of commensal bacteria, but mucosal surfaces are major entry sites
for pathogens, which overcome the defense mechanisms in the lumen and
attack the cells in the mucosal barrier. Activation of mucosal
inflammation is a major step in disease pathogenesis and a unifying
feature of the response to many mucosal pathogens. Yet, specific
virulence factors and molecular interactions with host cells cause
different aspects of the inflammatory response to be activated,
different cell types to be recruited, and thus unique disease patterns.
|
RELEVANCE OF URINARY TRACT INFECTION AS A MODEL OF
NEUTROPHIL-DEPENDENT ANTIMICROBIAL HOST DEFENSE
|
|---|
Urinary tract infections (UTIs) activate a mucosal
inflammatory response. Neutrophils dominate the acute cellular
infiltrate and migrate rapidly through the tissues and into the urine.
On their way, they participate in bacterial clearance, and the
neutrophil-dependent "innate" defense is more important than
specific immunity to maintain the sterility of the urinary tract
mucosa. Nude, xid, and SCID mice with defective
T-lymphocyte, immunoglobulin, or B- and T-lymphocyte function have been
shown to be fully resistant to UTIs [1
], as are
TCR
/ß, TCR
/
and RAG knockout mice [2
],
suggesting that specific lymphocyte populations do not contribute to
the defense. In contrast mouse strains with inherited or induced
neutrophil response defects are highly susceptible to infection and
develop symptomatic diseases or asymptomatic bacterial carriage.
C3H/HeJ mice (Tlr4-) are highly susceptible to
experimental UTI [3
], and these mice show a defective
neutrophil response to infection [4
]. Neutrophil
depletion renders normal mice as susceptible to UTI as C3H/HeJ mice
[5
], confirming the importance of neutrophils for
defense. Still, the C3H/HeJ mice remain asymptomatic, and there is no
evidence of tissue damage despite the large bacterial numbers in
kidneys and bladders, suggesting that the signaling pathways involved
in the inflammatory response are defective in these mice. Furthermore,
the results implicate that additional neutrophil response defects might
account for other aspects of disease.
These observations stimulated us to study (1) mechanisms by which
bacteria do trigger mucosal inflammation and (2) molecular interactions
of neutrophils with urinary tract mucosa.
|
BACTERIAL ACTIVATION OF MUCOSAL INFLAMMATION
|
|---|
The inflammatory response of the urinary tract is
initiated when bacteria reach epithelial cells and stimulate them to
secrete chemokines and to express chemokine receptors (Fig. 1
and
Fig. 2
). Different bacterial virulence factors cooperate to trigger the
mucosal response [6
7
8
9
]. We have focussed on attachment,
because this is the first step in disease pathogenesis and enables
pathogens to target their site of infection.
View larger version (89K):
[in this window]
[in a new window]
|
Figure 2. Chemokine response to E. coli infection of the human
urinary tract mucosa. (a) Biopsy specimens were obtained from the human
urinary tract and were exposed to uropathogenic E. coli in
vitro. The increase in epithelial-cell IL-1, IL-6, and IL-8 content was
detected by immunohistochemistry using monoclonal antibodies. For IL-8
a biphasic pattern was observed. First, preformed IL-8 was secreted,
then new IL-8 was synthesized and secreted. (b) mRNA repertoire
of uroepithelial cells after in vitro infection with E.
coli strains differing in fimbrial expression. The fimbriae were
shown to influence the chemokine repertoire of the cells.
pap+, prs+, P-fimbriated transformants;
pap-, E. coli K-12 host strain not expressing P
fimbriae; fim+, type 1 fimbriated; fimH-,
deletion in the fimH gene. fim-, E. coli
K-12 host strain not expressing type 1 fimbriae._art>
|
|
Attachment, transmembrane signaling, and inflammation
The uropathogens achieve tissue-specific attachment through the
expression of surface fimbriae. Their lectin-like domains recognize
oligosaccharide receptor epitopes on epithelial cell surface
glycolipids or glycoproteins. The resulting specific adherence was
initially thought only to promote colonization of the urinary tract,
but adherence has also been identified as a virulence factor
[6
], facilitating chemokine activation and mucosal
inflammation. Indeed, this is one explanation for the strong link
between attachment and virulence that was observed in the early
clinical studies [6
].
Attachment promotes inflammation by two general mechanisms. The
bacteria may themselves activate the target cells through
receptor-determined pathways [10
] or deliver other
virulence factors [11
12
13
] in a molecular context that
allows them to trigger a host response. Evidence for direct cell
activation by fimbria-receptor interaction has been obtained for
P and type 1 fimbriae. Both lectins mediate attachment to
uroepithelial cells and stimulate an epithelial cytokine response, but
they recognize different glycoconjugate receptors and activate
different transmembrane signaling pathways. P fimbriae bind glycolipid
receptors and activate the epithelial cells via a ceramide- and
TLR4-dependent signaling pathway [10
13 ]. Type 1
fimbriae bind mannosylated glycoproteins on a variety of cells
including neutrophils, but the signaling mechanism(s) involved in
epithelial cell activation is not understood [14
].
P-fimbriated Escherichia coli trigger
mucosal chemokine responses
P fimbriae bind to glycosphingolipid (GSL) receptors in the
uroepithelial cells [15
]. The receptor specificity is
defined by the oligosaccharide portion of the GSLs and specifically by
a Gal1-4Galß disaccharide motif [15
]. The receptor
GSLs lack a transmembrane domain but are bound to ceramide in the outer
leaflet of the lipid bilayer [16
]. P-fimbriated E.
coli stimulate an increase in intracellular ceramide levels with a
simultaneous decrease in surface-expressed receptor-active GSLs,
suggesting that ceramide is released by hydrolysis of the receptor
itself [10
, 17
]. Release and
phosphorylation of ceramide are detected within a few minutes after
exposure to P-fimbriated E. coli and the signaling involved
Ser/Thr protein kinases, because chemokine responses to P-fimbriated
E. coli are blocked in the presence of Ser/Thr protein
kinase inhibitors [10
]. This signaling pathway is
selectively activated by P fimbriae, because isogenic E.
coli strains expressing fimbriae with another receptor specificity
fail to release ceramide [10
14
].
P fimbriae recruit TLR4 as
coreceptors in cell signaling
Toll receptors and especially TLR4 are important for host
cell recognition of microbial molecules like lipopolysaccharide (LPS)
(Fig. 3
). A role for TLR4 in mucosal responses to P-fimbriated bacteria
was suspected from early studies in C3H/HeJ mice, which fail to respond
to experimental UTI [3
4
5
]. The TLR4- mice
produce a signaling-deficient form of the TLR4 protein and are found to
be completely unresponsive to infection with P-fimbriated E.
coli. Yet they respond to isogenic E. coli strains
expressing fimbriae with another receptor specificity, suggesting that
the P fimbriae target critical aspects of the TLR4-dependent signaling.
In vitro studies have show that human uroepithelial cells express
several TLR species, but only TLR4 expression is enhanced by
P-fimbriated strains. By confocal microscopy, TLR4 was shown to
colocalize with the GSL receptors recognized by P fimbriae and to be
located in caveoli. We propose that P fimbriae first bind to the GSL
receptors and then recruit TLR4s as coreceptors in signal transduction
[13
].
View larger version (28K):
[in this window]
[in a new window]
|
Figure 3. TLR4 activation in macrophages and epithelial cells may involve
different primary receptors. (a) LPS from gram-negative bacteria like
the uropathogens activates macrophages (MØ) via the CD14 receptor. LPS
bound to LPS-binding protein (LPB) is catalytically transferred to
CD14, and subsequently TLR4 is recruited as a coreceptor for signal
transduction. (b) The human urothelium is CD14 negative, and
uroepithelial cells respond poorly to soluble LPS. Still, chemokine
responses are triggered by uropathogenic bacteria, and this process is
enhanced by the fimbriae. Nonfimbriated bacteria are less
virulent and fail to deliver an activating signal to the cells. (c) P
fimbriae first bind their GSL receptor and then recruit TLR4 for
transmembrane signaling and cell activation. In this way they overcome
the LPS refractoriness of the uroepithelial cells, and activate a
chemokine response._art>
|
|
Activation of uroepithelial cells by P-fimbriated
E. coli is independent of LPS-CD14
LPS is regarded as the main proinflammatory factor in
gram-negative-bacterial infection [18
19
20
]. After
release from bacteria, LPS is bound to LPS-binding protein and is
transferred to a binding site on either membrane-bound CD14 or soluble
CD14 [19
, 21
, 22
]. Because
membrane-bound CD14 is glycosylphosphatidyl anchored and thereby lacks
a transmembrane domain, it requires a coreceptor for signal
transduction; Toll-like receptors have been shown to serve this
function. Indeed, a mutation in TLR4 explains the lack of LPS
responsiveness in C3H/HeJ mice [22
].
The host response induction by P fimbriae implicates a role for
LPS because LPS is the only established agonist of the TLR4 pathway.
Several observations have suggested that this is not the case in our
model. The uroepithelial cells are CD14 negative and do not become
activated by free LPS even in the presence of human serum. They respond
to whole bacteria and secrete chemokines, but these responses are not
inhibited by molecules like polymyxin B or
bactericidal/permeability-increasing protein, which inactivate LPS in
other systems [10
, 13
, 14
].
Furthermore, inactivation of the endotoxic activity of lipid A in whole
bacteria by mutation of the msbB sequences did not change
the response to P-fimbriated bacteria.
The results suggest that the P fimbriae utilize an LPS-like cell
activation mechanism in cells that lack CD14 and are refractory to LPS
itself [13
]. It thus appears that the GSL receptors on
epithelial cells serve a function similar to that of CD14 on
macrophages. Whereas LPS targets TLR4 via CD14, the P fimbriae may
activate TLR4 via their GSL receptors. In this way they overcome the
mucosal LPS barrier that normally controls inflammation (Fig. 3)
.
Furthermore, findings illustrate how the receptor specificity of
the fimbriae and the nature of their cell surface receptors influence
the transmembrane-signaling pathways involved in chemokine activation.
As a consequence, fimbriae may be expected to direct the repertoire of
cytokines expressed by infected epithelial cells. Bacteria "play"
on the host response repertoire, through the receptor specificity of
their adhesins, and thus activate different aspects of the host
response repertoire.
|
MOLECULAR MECHANISMS OF NEUTROPHIL RECRUITMENT
|
|---|
Because epithelial cells are the first to encounter mucosal
pathogens, they determine the hierarchy of molecular interactions
involved in the subsequent recruitment of other cell types and the
composition of the inflammatory infiltrate at the mucosa (Fig. 1
and
Fig. 4
). By studying epithelial-cell responses to microbial stimuli,
molecular determinants of neutrophil recruitment and transepithelial
neutrophil migration have been identified [24
25
26
27
].
View larger version (26K):
[in this window]
[in a new window]
|
Figure 4. IL-8 and CXCR1 are involved in transepithelial neutrophil
migration (a). Epithelial cell layers in transwell inserts were
stimulated for 24 h with uropathogenic E. coli in the
lower well, neutrophils were added to the upper well, and
transmigration was quantified after 3 h. The epithelial cells were
found to increase their expression of IL-8 and of the CXCR1 and CXCR2
chemokine receptors. Antibodies to IL-8 or CXCR1 blocked neutrophil
transmigration, demonstrating the involvement of these molecules in
neutrophil-epithelial cell interactions (b). _art>
|
|
Epithelial chemokine responses to infection
Epithelial cells respond to uropathogenic E. coli
by secreting interleukin (IL)-8. As IL-8 was the first uroepithelial
chemokine to be identified, it is the most extensively studied in terms
of its involvement in epithelial-neutrophil interactions. In the
transwell model, anti-IL-8 antibodies have been shown to block
neutrophil migration across infected epithelial cell layers (Fig. 2
and 4) [24
]. Recombinant IL-8 is able to support this
process in the absence of a bacterial stimulus, showing that IL-8 is
sufficient to support transepithelial neutrophil migration.
The in vitro data have largely been corroborated in vivo.
Epithelial cells in the human urinary tract mucosa synthesize IL-8
[29
], and a rapid increase in urine IL-8 concentrations
occurs after intravesical infection of human patients
[29
30
31
]. In deliberately colonized patients, there is a
strong correlation of urinary IL-8 levels with urinary neutrophil
numbers, and anti-IL-8 antibodies reduce the in vitro neutrophil
chemotactic activity of urine obtained from patients with UTI by 50%
[31
], supporting a role of IL-8 in the process of
neutrophil recruitment [29
].
In vivo studies in the murine UTI model have identified
macrophage-inflammatory protein (MIP)-2 as an important IL-8 equivalent
in the urinary tract [5
]. Infection causes a rapid
epithelial MIP-2 response; neutrophils are recruited, and antibodies to
MIP-2 have been shown to block neutrophil migration across the barrier
in vivo. Indeed, antibody treatment blocks their passage into the urine
and causes the neutrophils to accumulate under the kidney and bladder
epithelium, demonstrating that epithelial activation is essential and
confirming the importance of chemokines like IL-8 for the movement of
neutrophils in the peripheral compartment.
Influence of bacterial attachment on the epithelial chemokine
repertoire
Uropathogenic E. coli stimulate a wide range of
epithelial CXC (IL-8, GRO-, IP-10, MIG) and CC (MCP-1, MIP-1)
chemokines in addition to IL-8 [2
]. The epithelial
expression of IL-8 and MCP-1 mRNA increased rapidly after infection
with uropathogenic E. coli and declined after 24 h
(Fig. 2)
, suggesting that secretion of these two chemokines by
epithelial cells is more important during the acute inflammatory
response than during the chronic phase. The rapid kinetics of IL-8 and
MCP-1 mRNA production and secretion after E. coli infection
correlates well with the increased neutrophil influx into the urine
that is observed at the onset of UTI. One of the most important
proinflammatory functions of kidney epithelial cells might indeed be to
provide signals for inflammatory cells like neutrophils.
Fimbria-mediated attachment influences the chemokine response
repertoire [33
34
35
]. Type 1 fimbriated strains have been
shown to elicit mainly neutrophil-activating chemokines (e.g., IL-8 and
GRO-), whereas the P fimbriae trigger a chemokine repertoire
favoring the recruitment of many different cell types, including
lymphocytes and monocytes, in addition to neutrophils (e.g., MCP-1 and
MIP-1). For example, the early MCP-1 response may activate mast
cells, macrophages, monocytes, and even neutrophils as receptors for
MCP-1 are found on all of these cells [36
,
37
]. The involvement of these cell types in the chronic
inflammatory infiltrate of the kidney and bladder needs further study.
Epithelial chemokine receptor expression increases in response to
infection
IL-8 mediates its biological activity through the
G-protein-coupled receptors CXCR1 and CXCR2. Several cell types have
been shown to express CXCR1 and CXCR2, including endothelial cells
[37
], basophils [38
], dendritic cells
[39
], mast cells [40
], type 1 helper
cells [41
], and eosinophils [42
], but
these receptors have been most extensively studied on neutrophils. (For
review see 32.) Both CXCR1 and CXCR2 on neutrophils stimulate the
release of granule enzymes, exocytosis, and intracellular
Ca2+ mobilization, but the respiratory burst and activation
of phospholipase D depend exclusively on stimulation through CXCR1
[44
]. It should be noted that IL-8 mediates its effect
on neutrophil chemotaxis predominately through CXCR1, even though IL-8
can induce changes in chemotaxis and calcium concentration through
CXCR2 as well [32
, 40
41
42
43
44
45
46
47
48
].
We have shown that infection stimulates CXCR1 and CXCR2
expression also in human urinary tract epithelium. CXCR1 has been shown
to play a crucial role in neutrophil migration across infected human
uroepithelial cell layers in vitro [47
], because
anti-CXCR1 antibodies inhibit neutrophil migration, but anti-CXCR2
antibodies have no effect. These experiments suggest that CXCR1 is the
essential receptor in this process.
Aberrant neutrophil migration in mIL-8Rh mice
The importance of the chemokine receptors for the mucosal
inflammatory response has been further studied in murine IL-8 receptor
knockout (mIL-8Rh KO) mice. Mice have a single functional receptor for
the chemokines homologous to IL-8. This murine IL-8 receptor homologue
(mIL-8Rh) shares 69% and 71% amino acid identity with the human IL-8
receptors CXCR1 and CXCR2, respectively [47
]. The
neutrophils of the mIL-8Rh KO mice fail to migrate in response to the
CXC chemokines but have intact sensitivity for other activation
pathways [49
].
The in vivo relevance of epithelial CXCR expression was confirmed
in these mIL-8Rh KO mice. We subjected them to intravesical infection
with uropathogenic E. coli and examined the neutrophil
response in kidneys and bladders.The mice had an intact
epithelial chemokine response, as determined by MIP-2 staining, and
intact secretion of MIP-2 into the urine during the first hours after
infection, showing that the IL-8 receptor deficiency did not influence
the chemokine response per se [49
]. With
time, a difference in tissue distribution of MIP-2 was noticed compared
with that in the control mice [50
]. The MIP-2 response
decreased in controls, but the mIL-8Rh KO mice continued to produce
MIP-2, suggesting impaired down-regulation and/or continued stimulation
of this response. The chemokine receptors may, indeed, be essential
also to sequester the chemokine at the site of production.
The mIL-8Rh KO mice had a dysfunctional neutrophil response
compared with the BALB/c controls. The defect was not mainly in
neutrophil recruitment into the tissues but in the ability of these
neutrophils to cross the epithelial barrier and to kill the bacteria.
Even if the influx of neutrophils was somewhat delayed compared with
that in the controls, the neutrophils did reach bladder and kidney
tissue after about 24 h, showing that the chemotactic gradient was
intact and that chemotactic signals not depending on the IL-8 receptor
are involved in this process. These signals have not been identified.
In control mice, the neutrophil influx was transient, and the
neutrophils crossed the epithelial barrier into the lumen, resulting in
pyuria. In the mIL-8Rh KO mice, the neutrophils were unable to cross
the epithelium into the lumen, resulting in low urine neutrophil
numbers at all times. The neutrophils accumulated in large numbers
under the epithelium and eventually filled the tissues. The results
demonstrate that the epithelium forms a virtually impermeable barrier
to the neutrophils in the absence of IL-8 receptors and that chemokines
and chemokine receptors regulate the interaction of neutrophils with
epithelial cells in vivo.
These experiments illustrate the compartmentalization of the
signals and effector molecules involved in neutrophil migration.
Apparently, the vessel wall and mucosal barrier present quite different
challenges to the migrating neutrophil. Epithelial cells are the last
to encounter the neutrophils on the way through the tissues, and thus
they must have a different function than that of endothelial cells. The
occurrence of CXCR1 and CXCR2 on endothelial cells is still
controversial, and their function in neutrophil extravasation is
unknown. Heparan sulfates and Duffy antigen receptors have been
proposed to play a major role in IL-8 immobilization on the endothelial
cell surface and neutrophil transendothelial migration
[51
]. Thus it appears that different molecular
interactions may guide the neutrophils in the circulatory system or in
the periphery, at the site of infection. The epithelial cells probably
provide a more stable source of chemokines and may maintain their
expression of chemokines and chemokine receptors longer than the
endothelial cells. This may be essential to direct activated
neutrophils away from the tissues.Mucosal surfaces may
indeed be useful "burying grounds" where old neutrophils go to die.
|
NEUTROPHIL EFFECTOR FUNCTIONS AT THE MUCOSAL BARRIER
|
|---|
IL-8Rh KO mice develop acute
pyelonephritis
The IL-8 receptor mutation had dramatic effects on disease
susceptibility. The control mice eliminated bacteria from the tissues
in a few days and did not develop symptoms of infection. In the KO
mice, bacterial numbers increased in kidneys and bladders, and the mice
developed bacteremia and symptoms of systemic disease
[49
, 50
].
IL-8Rh KO mice develop renal scarring
Accumulation of neutrophils in the tissues of mIL-8Rh KO
mice results in tissue destruction, resembling renal scarring in humans
[51
]. After 7 days, control mice were healthy, and
infection was cleared, but mIL-8Rh KO mice had swollen kidneys with
neutrophil abscesses. After 35 days, they had developed kidney
pathology and renal scarring (Fig. 5
) [50
]. Fibrosis developed under the epithelium and
in the perivascular
space.
View larger version (128K):
[in this window]
[in a new window]
|
Figure 5. Renal scarring in mIL-8 Rh KO mice. Kidneys were obtained
from the mIL-8 Rh KO mice 35 days after infection with
uropathogenic E. coli. Macroscopically they were pale,
small and with abscesses and fibrotic areas. By histology,
subepithelial and perivascular fibrosis was observed. a) Pelvic
epithelium. Arrows indicate fibrosis. b) Perivascular fibrosis. c) and
d) Neutrophil infiltration._art>
|
|
We concluded that inactivation of a single gene encoding the
mIL-8R molecule is sufficient to convert the mice from a resistant to a
susceptible phenotype in terms of acute-disease susceptibility and
chronic disease development. The chemokine receptors drive
transepithelial neutrophil migration. In their absence, the neutrophils
are trapped, and the tissues are destroyed.
IL-8Rh KO mice have a human
counterpart
There are considerable intraindividual differences in
the susceptibility to UTI and in the tendency to develop renal scarring
after acute pyelonephritis. Failure to resolve the local phase of acute
infection may cause renal scarring in children and lead to permanent
renal damage. The recurrence rate after a first episode of acute
pyelonephritis in children is estimated at between 30% and 40%. No
molecular explanations for the differences in disease susceptibility
have been offered.
The acute and chronic changes in the mIL-8Rh KO mouse closely
resembled human disease and suggested that similar mechanisms might
underlie the susceptibility in humans. This led us to examine CXCR1
expression in children with documented episodes of acute
pyelonephritis. Twelve children were enrolled in the initial study and
compared with 12 healthy age-matched controls with no history of UTI
[49
]. The neutrophil surface expression of CXCR1 was
examined with a fluorescein-activated cell sorter, and the cells were
inspected by confocal microscopy. Surface CXCR1 expression was lower
and more heterogeneous in the patients. Furthermore, the CXCR1 mRNA
expression in neutrophils was lower in the patients than in the
controls. Despite the small number of patients, we found significant
differences in receptor expression between patients and controls,
suggesting that these differences are highly relevant. There was no
evidence of a similar difference in CXCR2 expression.
Mutations in the CXCR1 gene
The low protein expression and the low mRNA levels
suggest that patients carry mutations that impair CXCR1 expression.
Both IL-8 receptor genes and a homologous pseudogene have been mapped
to position 2q34-35 in the human genome [52
53
54
]. This
region has been sequenced in patient and control DNA using primers for
the promoter region. Preliminary results are summarized in Figure 6
. We observed sequence heterogeneity in regions of the promoter
that are involved in transcription control. More extensive studies are
required to understand the disease implications of the observed
sequence variation.
View larger version (25K):
[in this window]
[in a new window]
|
Figure 6. CXCR1 promoter sequences in patients and controls. The single copy of
the human CXCR1 gene has been mapped to chromosome 2q34-q35. Two
full-length sequences deposited in the data base were identical except
for two bases in the second exon. The gene consists of two exons
interrupted by an intron of 1.7 kb, and the entire orf
encoded in exon 2 [52
, 53
]. The 5' region
upstream of exon 1 encodes the promoter, and further upstream (-841 to
-280) potential silencer elements were identified. The CXCR1 promoter
has an SP-1 transcription start site. Studies of promoter activity in
transfected cells have identified PU.1 of the ets family of
transcription factors as a major regulator of the CXCR1 promoter. The
PU.1 binding motif is located at -7 to -4, and disruption of these
sequences inactivates transcription [54
]. The low CXCR1
mRNA expression in children with UTI suggests that the promoter might
carry mutations in regions that regulate transcription. Primers for the
entire promoter region were constructed based on the published
sequences. DNA was isolated from the patients and age-matched controls
and subjected to DNA sequencing. Polymorphic sites in patient and
control children are shown in the figure. We concluded that the CXCR1
promoter region is polymorphic. Studies aimed at quantifying the
promoter activity from patients and controls are ongoing.
|
|
|
CONCLUSIONS
|
|---|
Mucosal infections are excellent models to study the
signals that initiate inflammation and the effector functions
determining whether health or disease will prevail (Fig. 1)
. We have
used UTI as a model to examine how bacteria trigger inflammatory
processes and to study the effects of inflammation on bacteria and
tissues. Uropathogenic E. coli use surface fimbriae and
their receptors to activate transmembrane signaling pathways involved
in chemokine responses. The stimulated epithelial cells then secreted
chemokines, and their chemokine receptor expression was enhanced. For
example, P-fimbriated E. coli bound cell surface glycolipid
receptors, released ceramide, and recruited TLR4 as coreceptors.
Neutrophils dominated in the inflammatory infiltrate of the
urinary tract, and the urinary tract epithelium regulated the
neutrophil response by secreting IL-8 and similar chemokines, which
directed neutrophil migration across the mucosal barrier into the
urine. Furthermore, infection enhanced the expression of the CXC
chemokine receptors, which also are required for neutrophil migration
across the epithelial barrier. mIL-Rh KO mice developed renal scarring
when the recruited neutrophils failed to cross the barrier into the
urinary tract lumen but accumulated under the epithelium.
The neutrophils played a crucial role in defense against
infection. Normal mice had a transient neutrophil response, during
which bacteria were eliminated from the tissues, but mice lacking a
neutrophil response or having the defect exhibited by the mIL-8Rh KO
mice failed to clear infection (Fig. 1)
.
Finally, we found that patients with recurrent UTI had low expression
of CXCR1 and that there were polymorphisms in the genes encoding these
receptors. These studies provide a first molecular handle on the
genetics of UTI. It is possible that discrete genetic defects underlie
disease susceptibility in this patient group.
|
ACKNOWLEDGEMENTS
|
|---|
This study was supported by grants from The Swedish Medical
Research Council (grant K97-06X-07934), The Crafoord, Wallenberg (grant
97.123) and Österlund Foundations and The Royal
Physiographic Society. C. S. is the recipient of a Bristol-Myers
Squibb "unrestricted grant."
Received February 2, 2001;
revised May 4, 2001;
accepted May 4, 2001.
|
REFERENCES
|
|---|
-
Svanborg-Edén, C., Hagberg, L., Briles, D., McGhee, J., Michalek, S. (1985) Susceptibility to Escherichia coli urinary tract infection and LPS responsiveness Skamene, E. eds. Genetic Control of Host Resistance to Infection and Malignancy 3,385-398 Alan R. Liss, Inc. New York.
-
Frendeus, B., Godaly, G., Hang, L., Karpman, D., Svanborg, C. (2001) Interleukin-8 receptor deficiency confers susceptibility to acute pyelonephritis J. Infect. Dis. 183(Suppl),S56-S60
-
Hagberg, L., Briles, D., Svanborg-Edén, C. (1985) Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice that affect the susceptibility to gram-negative infections J. Immunol. 134,4118-4122[Abstract]
-
Shahin, R. D., Engberg, I., Hagberg, L., Svanborg-Eden, C. (1987) Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection J. Immunol. 138,3475-3480[Abstract]
-
Haraoka, M., Hang, L, Frendéus, B., Godaly, G., Burdick, M., Strieter, R., Svanborg, C. (1999) Neutrophil recruitment and resistance to mucosal infection with uropathogenic Escherichia coli J. Infect. Dis. 180,1220-1229[Medline]
-
Svanborg-Edén, C., Hanson, L. A., Jodal, U., Lindberg, U., Sohl-Åkerlund, A. (1976) Variable adherence to normal urinary tract epithelial cells of Escherichia coli strains associated with various forms of urinary tract infections Lancet ii,490-492
-
Svanborg-Edén, C., Hansson, S., Jodal, U., Lidin-Janson, G., Lincoln, K., Linder, H., Lomberg, H., de Man, P., M
rild, S., Martinell, J., Plos, K., Sandberg, T., Stenquist, K. (1988) Host-parasite interaction in the urinary tract J. Infect. Dis. 157,421-426[Medline]
-
Johnson, J. (1991) Virulence factors in Escherichia coli urinary tract infection Clin. Microbiol. Rev. 4,80-128[Abstract/Free Full Text]
-
Hacker, J., Kaper, J. B. (2000) Pathogenicity islands and the evolution of microbes Annu. Rev. Microbiol. 54,641-679[Medline]
-
Hedlund, M., Svensson, M., Nilsson, Å., Duan, R., Svanborg, C. (1996) Role of the ceramide signalling pathway in cytokine responses to P fimbriated Escherichia coli J. Exp. Med. 183,1-8[Free Full Text]
-
Smith, H. W., Lingwood, M. A. (1972) Further observations on Escherichia coli enterotoxins with particular regard to those produced by atypical piglet strains and by calf and lambs strains: the transmissable nature of these enterotoxins and of a K antigen possessed by calf and lamb strains J. Med. Microbiol. 5,243-250[Medline]
-
Sansonetti, P. J. (2001) Rupture, invasion and inflammatory destruction of the intestinal barrier by Shigella, making sense of prokaryote-eukaryote cross-talks FEMS Microbiol. Rev. 25,3-14[Medline]
-
Frendeus, B., Wachtler, C., Hedlund, M., Fischer, H., Samuelsson, P., Svensson, M., Svanborg, C. (2001) Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation Mol. Microbiol. 40,37-51[Medline]
-
Hedlund, M., Frendeus, B., Wachtler, C., Hang, L., Fischer, H., Svanborg, C. (2001) Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells Mol. Microbiol. 39,542-552[Medline]
-
Leffler, H., Svanborg-Edén, C. (1980) Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes FEMS Microbiol. Lett. 8,127-134
-
Hannun, Y. A., Bell, R. M. (1989) Functions of sphingolipids and sphingolipid breakdown products in cellular regulation Science 243,500-507[Abstract/Free Full Text]
-
Hedlund, M., Duan, R. D., Nilsson, A., Svanborg, C. (1998) Sphingomyelin, glycosphingolipids and ceramide signalling in cells exposed to P-fimbriated Escherichia coli Mol. Microbiol. 29,1297-1306[Medline]
-
Ulevitch, R. J., Tobias, P. S. (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin Annu. Rev. Immunol. 13,437-457[Medline]
-
Rietschel, E. T., Brade, H. (1992) Bacterial endotoxins Sci. Am. 267,54-61[Medline]
-
Hailman, E., Lichenstein, H. S., Wurfel, M. M., Miller, D. S., Johnson, D. A., Kelley, M., Busse, L. A., Zukowski, M. M., Wright, S. D. (1994) Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14 J. Exp. Med. 179,269-277[Abstract/Free Full Text]
-
Tobias, P. S., Soldau, K., Gegner, J. A., Mintz, D., Ulevitch, R. J. (1995) Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14 J. Biol. Chem. 270,10482-10488[Abstract/Free Full Text]
-
Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., Beutler, B. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene Science 282,2085-2088[Abstract/Free Full Text]
-
Hedlund, M., Wachtler, C., Johansson, E., Hang, L., Somerville, J. E., Darveau, R. P., Svanborg, C. (1999) P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses Mol. Microbiol. 33,693-703[Medline]
-
Godaly, G., Proudfoot, A. E. I., Offord, R. E., Svanborg, C., Agace, W. (1997) Role of epithelial interleukin-8 and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration Infect. Immun. 65,3451-3456[Abstract]
-
Cramer, E. B., Milks, L. C., Ojakian, G. K. (1980) Transepithelial migration of human neutrophils: an in vitro model system Proc. Natl. Acad. Sci. USA 77,4069-4073[Abstract/Free Full Text]
-
Parkos, C. A., Delp, C., Arnout, M. A., Madara, J. L. (1991) Neutrophil migration across cultured intestinal epithelium: dependence on a CD11b/CD18-mediated event and enhanced efficiency in the physiologic direction J. Clin. Invest. 88,1605-1612
-
Agace, W., Patarroyo, M., Svensson, M., Carlemalm, E., Svanborg, C. (1995) Escherichia coli induce trans-uroepithelial neutrophil migration by an ICAM-1 dependant mechanism Infect. Immun. 63,4045-4062
-
Hang, L., Wullt, B., Shen, Z. X., Karpman, D., Svanborg, C. (1998) Cytokine repertoire of epithelial cells lining the human urinary tract J. Urol. 159,2185-2192[Medline]
-
Agace, W., Hedges, S., Ceska, M., Svanborg, C. (1993) IL-8 and the neutrophil response to mucosal gram negative infection J. Clin. Invest. 92,780-785
-
Agace, W., Hedges, S., Andersson, U., Andersson, J., Ceska, M., Svanborg, C. (1993) Selective cytokine production by epithelial cells following exposure to Escherichia coli Infect. Immun 61,602-609[Abstract/Free Full Text]
-
Ko, Y. C., Mukaida, N., Ishiyama, S., Tokue, A., Kawai, T., Matsushima, K., Kasahara, T. (1993) Elevated interleukin-8 levels in the urine of patients with urinary tract infections Infect. Immun. 61,1307-1314[Abstract/Free Full Text]
-
Baggiolini, M., Dewald, B., Moser, B. (1997) Human chemokines: an update Annu. Rev. Immunol. 15,675-705[Medline]
-
Svensson, M., Lindstedt, R., Radin, N., Svanborg, C. (1994) Epithelial glycosphingolipid expression as a determinant of bacterial adherence and cytokine production Infect. Immun. 62,4404-4410[Abstract/Free Full Text]
-
Godaly, G., Frendéus, B., Prodfoot, A., Svensson, M., Klemm, P., Svanborg, C. (1998) Role of fimbriae-mediated adherence for neutrophil migration across Escherichia coli-infected epithelial cell layers Mol. Microbiol. 30,725-735[Medline]
-
Abraham, S. N., Arock, M. (1998) Mast cells and basophils in innate immunity Semin. Immunol. 10,373-381[Medline]
-
Johnston, B., Burns, A. R., Suematsu, M., Issekutz, T. B., Woodman, R. C., Kubes, P. (1999) Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1 J. Clin. Invest. 103,1269-1276[Medline]
-
Middleton, J., Neil, S., Wintle, J., Clark-Lewis, I., Moore, H., Lam, C., Auer, M., Hub, E., Rot, A. (1997) Transcytosis and surface presentation of IL-8 by venular endothelial cells Cell 91,385-395[Medline]
-
Ochensberger, B., Tassera, L., Bifrare, D., Rihs, S., Dahinden, C. A. (1999) Regulation of cytokine expression and leukotriene formation in human basophils by growth factors, chemokines and chemotactic agonists Eur. J. Immunol. 29,11-22[Medline]
-
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., Lanzavecchia, A. (1998) Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation Eur. J. Immunol. 28,2760-2769[Medline]
-
Lippert, U., Artuc, M., Grutzkau, A., Moller, A., Kenderessy-Szabo, A., Schadendorf, D., Norgauer, J., Hartmann, K., Schweitzer-Stenner, R., Zuberbier, T., Henz, B. M., Kruger-Krasagakes, S. (1998) Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells J. Immunol. 1,2600-2608
-
Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., Sinigaglia, F. (1998) Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s J. Exp. Med. 187,129-134[Abstract/Free Full Text]
-
Petering, H., Gotze, O., Kimmig, D., Smolarski, R., Kapp, A., Elsner, J. (1999) The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils Blood 93,694-702[Abstract/Free Full Text]
-
Green, S. P., Chuntharapai, A., Curnutte, J. T. (1996) Interleukin-8 (IL-8), melanoma growth-stimulatory activity, and neutrophil-activating peptide selectively mediate priming of the neutrophil NADPH oxidase through the type A or type B IL-8 receptor J. Biol. Chem. 271,25400-25405[Abstract/Free Full Text]
-
Hammond, M. E., Lapointe, G. R., Feucht, P. H., Hilt, S., Gallegos, C. A., Gordon, C. A., Giedlin, M. A., Mullenbach, G., Tekamp-Olson, P. (1995) IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors J. Immunol. 155,1428-1433[Abstract]
-
Quan, J. M., Martin, T. R., Rosenberg, G. B., Foster, D. C., Whitmore, T., Goodman, R. B. (1996) Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis Biochem. Biophys. Res. Commun. 219,405-411[Medline]
-
Godaly, G., Hang, L., Frendéus, B., Svanborg, C. (2000) Transepithelial neutrophil migration is CXCR1 dependant in vitro and is defective in IL-8 receptor mutant mice J. Immunol. 165,5287-5294[Abstract/Free Full Text]
-
Cacalano, G., Le, J., Kikly, K., Ryan, A .M., Pitts-Meek, S., Hultgren, B., Wood, W. I., Moore, M. W. (1994) Neutrophil and B cell expansion in mice that lack the murine IL-8
receptor homolog Science 265,682-684[Abstract/Free Full Text]
-
Lee, J., Cacalano, G., Camerato, T., Toy, K., Moore, M. W., Wood, W. I. (1995) Chemokine binding and activities mediated by the mouse IL-8 receptor J. Immunol. 155,2158-2164[Abstract]
-
Frendéus, B., Godaly, G., Hang, L., Karpman, D., Svanborg, C. (2000) IL-8R deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart J. Exp. Med. 192,881-890[Abstract/Free Full Text]
-
Hang, L, Frendeus, B, Godaly, G, Svanborg, C. (2000) Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis J. Infect. Dis. 182,1738-1748[Medline]
-
Witt, D. P., Lander, A. D. (1994) Differential binding of chemokines to glycosaminoglycan subpopulations Curr. Biol. 4,394-400[Medline]
-
Ahuja, S. K., Ozcelik, T., Milatovitch, A., Francke, U., Murphy, P. M. (1992) Molecular evolution of human interleukin-8 receptor gene cluster Nat. Genet. 2,31-36[Medline]
-
Lloyd, A., Modi, W., Sprenger, H., Cevario, S., Oppenheim, J., Kelvin, D. (1993) Assignment of genes for interleukin-8 receptors (IL8R) A and B to human chromosome band 2q35 Cytogenet. Cell. Genet. 63,238-240[Medline]
-
Wilkinson, N. C., Navarro, J. (1999) PU.1 regulates the CXCR1 promoter J. Biol. Chem. 274,438-443[Abstract/Free Full Text]
This article has been cited by other articles:
|
|
|
|
 
V. Pinho, R. de Castro Russo, F. A. Amaral, L. P. de Sousa, M. M. Barsante, D. G. de Souza, J. C. Alves-Filho, D. C. Cara, J. S. Hayflick, C. Rommel, et al.
Tissue- and Stimulus-Dependent Role of Phosphatidylinositol 3-Kinase Isoforms for Neutrophil Recruitment Induced by Chemoattractants In Vivo
J. Immunol.,
December 1, 2007;
179(11):
7891 - 7898.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Galioto, J. A. Hess, T. J. Nolan, G. A. Schad, J. J. Lee, and D. Abraham
Role of Eosinophils and Neutrophils in Innate and Adaptive Protective Immunity to Larval Strongyloides stercoralis in Mice.
Infect. Immun.,
October 1, 2006;
74(10):
5730 - 5738.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Galanakis, M. Bitsori, H. Dimitriou, C. Giannakopoulou, N. S. Karkavitsas, and M. Kalmanti
Urine Interleukin-8 as a Marker of Vesicoureteral Reflux in Infants
Pediatrics,
May 1, 2006;
117(5):
e863 - e867.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Jiang, P. Oliver, K. E. Davies, and N. Platt
Identification and Characterization of Murine SCARA5, a Novel Class A Scavenger Receptor That Is Expressed by Populations of Epithelial Cells
J. Biol. Chem.,
April 28, 2006;
281(17):
11834 - 11845.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Smithson, M. R. Sarrias, J. Barcelo, B. Suarez, J. P. Horcajada, S. M. Soto, A. Soriano, J. Vila, J. A. Martinez, J. Vives, et al.
Expression of Interleukin-8 Receptors (CXCR1 and CXCR2) in Premenopausal Women with Recurrent Urinary Tract Infections
Clin. Vaccine Immunol.,
December 1, 2005;
12(12):
1358 - 1363.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Farkas, M.-C. Hahn, M. Schmoczer, N. Jentsch, K. Kratzel, M. Pfeifer, and C. Schulz
Expression of CXC Chemokine Receptors 1 and 2 in Human Bronchial Epithelial Cells
Chest,
November 1, 2005;
128(5):
3724 - 3734.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Samuelsson, L. Hang, B. Wullt, H. Irjala, and C. Svanborg
Toll-Like Receptor 4 Expression and Cytokine Responses in the Human Urinary Tract Mucosa
Infect. Immun.,
June 1, 2004;
72(6):
3179 - 3186.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Grimm, R. Newman, Z. Hassim, N. Cuan, S. J. Connor, Y. Le, J. M. Wang, J. J. Oppenheim, and A. R. Lloyd
Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors
J. Immunol.,
November 15, 2003;
171(10):
4990 - 4994.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Schilling, S. M. Martin, D. A. Hunstad, K. P. Patel, M. A. Mulvey, S. S. Justice, R. G. Lorenz, and S. J. Hultgren
CD14- and Toll-Like Receptor-Dependent Activation of Bladder Epithelial Cells by Lipopolysaccharide and Type 1 Piliated Escherichia coli
Infect. Immun.,
March 1, 2003;
71(3):
1470 - 1480.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Nebl, K. N. Pestonjamasp, J. D. Leszyk, J. L. Crowley, S. W. Oh, and E. J. Luna
Proteomic Analysis of a Detergent-resistant Membrane Skeleton from Neutrophil Plasma Membranes
J. Biol. Chem.,
November 1, 2002;
277(45):
43399 - 43409.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Fox-Marsh and L. C. Harrison
Emerging evidence that molecules expressed by mammalian tissue grafts are recognized by the innate immune system
J. Leukoc. Biol.,
March 1, 2002;
71(3):
401 - 409.
[Abstract]
[Full Text]
[PDF]
|
|
|
TOP
ABSTRACT
INTRODUCTION
